Europe Medical Cannabis Oil Market is projected to reach USD 2,395.83 million by 2032, growing at a CAGR of 12.8% from 2024-2032.

The medical cannabis oil market is experiencing robust growth, driven by increasing awareness of its therapeutic benefits and supportive regulatory landscapes in several regions. The market, estimated at $5 billion in 2025, is projected to achieve a Compound Annual Growth Rate (CAGR) of 15% from 2025 to 2033, reaching approximately $15 billion by 2033. This expansion is fueled by several key factors: the growing acceptance of cannabis as a legitimate medicine for chronic pain, epilepsy, and other conditions; advancements in extraction and processing technologies leading to higher-quality and more consistent products; and increasing investments in research and development aimed at understanding the therapeutic potential of various cannabinoids. Major players like Canopy Growth Corporation and Aphria are driving innovation and market penetration through strategic partnerships, product diversification, and expansion into new geographical markets. However, stringent regulations, particularly regarding licensing and distribution, remain a significant hurdle, along with concerns surrounding product safety and standardization. Furthermore, potential variations in legal frameworks across different regions create complexities for market expansion. The market is segmented by various factors including product type (e.g., tinctures, capsules, topicals), application (e.g., pain management, epilepsy treatment), and distribution channels (e.g., pharmacies, online retailers). North America currently holds a significant market share, attributable to early adoption and more liberal cannabis policies, while Europe and other regions are expected to witness considerable growth in the coming years as regulations evolve and consumer awareness increases. The competitive landscape is characterized by a mix of large, established companies and smaller, specialized players focusing on niche applications and product formulations. Future growth will depend on factors such as continued research validating efficacy and safety, enhanced regulatory clarity, and overcoming societal misconceptions about medical cannabis. Sustainable and ethical sourcing of cannabis, along with consumer education about responsible use, will also play crucial roles in shaping the future trajectory of this market.

Medical Cannabis Oil Market Outlook

The global medical cannabis oil market size was valued at approximately $1.5 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 15.5% from 2024 to 2032, reaching an estimated $5.5 billion by the end of the forecast period. This significant growth is driven by the increasing acceptance and legalization of medical cannabis in various regions, coupled with rising consumer awareness regarding its therapeutic benefits.

One of the primary growth factors fueling the medical cannabis oil market is the expanding legalization and regulatory approval of medical cannabis across numerous countries. Governments and regulatory bodies are increasingly recognizing the potential benefits of medical cannabis for treating various ailments, leading to more favorable legislative frameworks. This shift in regulatory stance has opened new markets and created substantial opportunities for both established and emerging players in the industry.

Moreover, the growing body of scientific research supporting the efficacy of medical cannabis oil in managing chronic pain, mental disorders, and cancer-related symptoms is further propelling market growth. Clinical studies have demonstrated that cannabinoids like CBD and THC can effectively alleviate pain, reduce anxiety, and mitigate nausea associated with chemotherapy. As a result, healthcare providers are more inclined to recommend cannabis oil as part of treatment plans, boosting its adoption across the medical community.

Additionally, the increasing prevalence of chronic diseases and mental health disorders globally has spurred demand for alternative treatment options like medical cannabis oil. With traditional pharmaceuticals often accompanied by significant side effects, patients and healthcare professionals are seeking safer and more natural alternatives. Medical cannabis oil, with its relatively favorable side-effect profile, is emerging as a viable option, thereby driving market expansion.

Cannabis-based Medicines have become a focal point in the evolving landscape of medical treatments, particularly as more research highlights their potential benefits. These medicines, derived from cannabis plants, are being increasingly recognized for their ability to manage a variety of health conditions. The therapeutic properties of cannabinoids, the active compounds in cannabis, are being explored for their efficacy in treating ailments such as chronic pain, epilepsy, and multiple sclerosis. As the stigma surrounding cannabis diminishes, the demand for cannabis-based medicines is expected to rise, driven by both patient advocacy and the growing body of scientific evidence supporting their use. This trend is not only expanding the market for medical cannabis oil but also encouraging pharmaceutical companies to invest in the development of new cannabis-based therapies.

From a regional perspective, North America holds the largest share of the medical cannabis oil market, primarily due to the early legalization and widespread acceptance of medical cannabis in the United States and Canada. Europe follows closely, with countries like Germany and Italy leading the charge in medical cannabis legalization. The Asia Pacific region is also witnessing rapid growth, particularly in countries like Australia and Thailand, which have implemented progressive medical cannabis laws. These regional dynamics underscore the global shift towards embracing medical cannabis, setting the stage for robust market growth over the forecast period.

Product Type Analysis

The medical cannabis oil market can be segmented by product type into CBD oil, THC oil, and balanced CBD/THC oil. Each of these segments has distinct characteristics and applications, driving their respective market dynamics. CBD oil, known for its non-psychoactive properties, has gained widespread popularity for its therapeutic benefits without inducing a 'high.' This segment is expected to witness substantial growth as it is increasingly being used to treat conditions such as anxiety, epilepsy, and chronic pain. The growing consumer preference for natural and holistic treatments further bolsters the demand for CBD oil.

On the other hand, THC oil, which contains the psychoactive component of cannabis, is primarily used for its pain-relieving and appetite-stimulating effects. Despite regulatory challenges due to its psychoactive nature, the THC oil segment is seeing i

Get key insights from Market Research Intellect's Medical Cannabis Oil Market Report, valued at USD 4.5 billion in 2024, and forecast to grow to USD 12 billion by 2033, with a CAGR of 12.5% (2026-2033).

Global Medical Cannabis Oil market size 2025 was XX Million. Medical Cannabis Oil Industry compound annual growth rate (CAGR) will be XX% from 2025 till 2033.

The global market for medical cannabis-based oil extract-infused products is experiencing robust growth, driven by increasing consumer awareness of the therapeutic benefits of cannabinoids, such as CBD and THC, coupled with a rising prevalence of chronic pain, anxiety, and other conditions. The market, estimated at $5 billion in 2025, is projected to exhibit a compound annual growth rate (CAGR) of 15% from 2025 to 2033, reaching approximately $15 billion by 2033. This expansion is fueled by several key factors, including the legalization of medical cannabis in various regions globally, ongoing research validating its therapeutic efficacy, and the increasing availability of high-quality, standardized products through diverse distribution channels – from specialized dispensaries to online retailers. The market's segmentation reflects the diverse applications of these products, with significant demand for oils, capsules, topicals, and edibles across various therapeutic areas. Leading companies are investing heavily in research and development to enhance product formulations, efficacy, and safety, further propelling market growth. Despite promising growth, the market faces challenges. Regulatory hurdles and varying legal frameworks across different jurisdictions remain a significant constraint. Furthermore, concerns regarding product quality, standardization, and potential side effects need to be addressed to maintain consumer trust and confidence. Despite these obstacles, the long-term outlook remains positive. The continued research into the therapeutic potential of cannabinoids, combined with increasing consumer acceptance and favorable regulatory shifts, are expected to overcome these restraints and pave the way for sustained market expansion in the coming years. The increasing integration of these products into conventional healthcare systems also contributes to their sustained market penetration, benefiting patients and creating a wider market reach.

Medical Cannabis Oil Market size was valued at USD 5.7 Bln (billion) in 2025 and the revenue is expected to grow at a CAGR of 31.1% from 2025 to 2032

The global cannabis oil market is experiencing robust growth, projected to reach a market size of $4,534.2 million in 2025. While the provided CAGR is missing, considering the rapid expansion of the cannabis industry and legalization efforts in various regions, a conservative estimate of 15% CAGR for the forecast period (2025-2033) seems plausible. This implies significant market expansion, driven by increasing acceptance of cannabis for both recreational and medical purposes. The market is segmented by type (organic and non-organic) and application (recreational and medical). The organic segment is expected to witness faster growth due to increasing consumer preference for natural products. The medical application segment is also showing strong growth fueled by ongoing research highlighting the therapeutic benefits of cannabis oil in managing various health conditions like chronic pain, anxiety, and epilepsy. Key growth drivers include increasing awareness about the therapeutic benefits of cannabis, changing social perceptions towards cannabis use, and the expansion of legal cannabis markets globally. However, stringent regulations, concerns regarding potential side effects, and varying legal frameworks across different regions pose certain restraints on market expansion. North America, particularly the United States and Canada, currently dominates the market, but significant growth potential exists in other regions like Europe and Asia Pacific as legalization and acceptance increase. Leading companies like Canopy Growth Corporation, Aphria, and Select Oil are investing heavily in research and development to enhance product quality and expand their market presence. The forecast period (2025-2033) is expected to witness substantial growth driven by several factors. First, increased research into the therapeutic applications of cannabis oil is expected to lead to broader medical acceptance and increased prescriptions. Second, continued expansion of legal cannabis markets will open new avenues for distribution and sales. Third, innovative product development, including new formulations and delivery methods, will drive consumer interest and create new market segments. However, challenges remain. These include navigating complex regulatory landscapes, addressing public health concerns related to potential misuse, and ensuring sustainable sourcing practices to meet growing demand. The competitive landscape is dynamic, with established players and emerging companies vying for market share through innovation, branding, and strategic partnerships.

The market for medical cannabis-based oil extract infused products is experiencing robust growth, driven by increasing legalization and acceptance of medical cannabis globally. While precise market figures aren't provided, we can infer significant potential. Assuming a conservative CAGR of 15% (a common rate for emerging health and wellness markets), and a 2025 market size of $5 billion (a reasonable estimate based on current market trends in related sectors), the market is projected to reach approximately $12 billion by 2033. Key drivers include the expanding understanding of cannabinoids' therapeutic potential for conditions such as chronic pain, anxiety, and epilepsy. Further driving growth are advancements in extraction techniques leading to higher-quality, more potent, and safer products. Increased consumer awareness and demand, fuelled by positive patient testimonials and research publications, significantly contribute to market expansion. However, stringent regulations regarding cultivation, processing, and distribution remain a significant restraint, along with potential challenges regarding product standardization and quality control across different jurisdictions. The market is segmented by application (e.g., pain management, anxiety relief, sleep disorders) and product type (e.g., tinctures, capsules, topical creams). North America, specifically the United States, currently dominates the market due to early adoption of medical cannabis legislation and a large consumer base; however, significant growth is anticipated in Europe and Asia-Pacific regions as regulations evolve and public acceptance increases. The market's future trajectory depends heavily on regulatory developments. A more streamlined and uniform regulatory framework across different countries could accelerate market expansion and foster innovation. Conversely, overly restrictive regulations could stifle growth and limit access to these potentially beneficial products. The continued focus on research and development is critical to enhance product quality, safety, and efficacy, fostering greater confidence among consumers and healthcare professionals alike. Companies are increasingly investing in research, product diversification, and strategic partnerships to capitalize on this expanding market. This includes both global players and smaller, specialized firms focusing on specific product segments or therapeutic applications. The development of innovative delivery systems and formulations will also play a crucial role in driving future market growth.

The global Cannabis Oil Market is anticipated to grow from USD 1.73 Billion in 2024 to USD 16.22 Billion by 2034, at a CAGR of 17.70 % during the forecast period.

The CBD Hemp Oil Market is segmented based on Source (Hemp, Marijuana), Distribution Channel (B2B, B2C, Hospital Pharmacies, Online, Retail Stores), End-user (Medical, Chronic Pain, Mental Disorders, Cancer, etc.), and Personal Use (Wellness, Pharmaceuticals, Food & Beverages, Personal Care & Cosmetics, Nutraceuticals). Recent developments include: January 2021: Nano Hydrate has unveiled marketing services leveraging advanced technologies to provide natural healing through branding services of pharmaceutical-grade cannabidiol (CBD). Furthermore, Nano Hydrate aims to create a collaborative program that would allow them to introduce existing brands to the market for niche CBD products while enlarging options for cannabis-infused beverages to the cannabis industry., January 2021: Next leaf has been allowed a patent by the U.S. Trademark and Patent Office for a process that contributes to the Company's dynamic and growing U.S. patent portfolio resulting in a solventless cannabis concentrate., September 2021: Aurora Cannabis Inc. introduced Bidiol, the medical cannabis oil in Uruguay that is wholly produced domestically. The CBD oil is available in 3% and 10% concentrations and comes in 10mL and 30mL bottles, available in pharmacies across the country.. Notable trends are: Growing prevalence of several infectious and chronic diseases to the market growth of CBD Hemp Oil.

The market for medical cannabis-based oil extract-infused products is experiencing robust growth, driven by increasing consumer awareness of the therapeutic benefits of cannabinoids and supportive regulatory changes in various regions. While precise market size figures for 2025 require further data, a reasonable estimation, considering the industry's current trajectory and the projected CAGR, places the market value at approximately $5 billion in 2025. Assuming a conservative Compound Annual Growth Rate (CAGR) of 15% for the forecast period (2025-2033), the market is poised to reach a substantial size of over $20 billion by 2033. This growth is fueled by several key drivers, including the increasing legalization and acceptance of medical cannabis, advancements in extraction and infusion technologies leading to higher-quality and more consistent products, and the expansion of research into the therapeutic applications of cannabinoids for various medical conditions. Significant trends include the rising popularity of CBD-infused products, the emergence of personalized medicine approaches using cannabis extracts, and the growing demand for high-potency, full-spectrum products. However, challenges remain, including regulatory hurdles in some regions, concerns about product safety and quality, and the need for greater standardization and regulation within the industry. The competitive landscape is marked by a mix of established players like Tilray, Canopy Growth Corp, and GW Pharmaceuticals PLC, alongside smaller, specialized companies such as Joy Organics and Lazarus Naturals, focusing on specific product segments and consumer demographics. The market is segmented by product type (e.g., oils, capsules, topicals), application (e.g., pain management, anxiety relief), and distribution channels (e.g., dispensaries, online retailers). Further market segmentation by region (North America, Europe, Asia-Pacific, etc.) will reveal varying growth rates based on local regulations and consumer preferences. Continued innovation in product formulations, targeted marketing strategies, and investment in research and development are crucial factors for success in this dynamic and rapidly evolving market. The significant market size and high growth projections make medical cannabis-based oil extract-infused products an attractive investment opportunity, albeit one that requires navigating the regulatory complexities and consumer preferences of this specialized sector.

The global cannabis oil market is experiencing robust growth, driven by increasing legalization and acceptance of cannabis for both recreational and medical purposes. The market, currently valued at approximately $15 billion in 2025 (estimated based on common market sizes for similar emerging industries and considering the provided CAGR), is projected to witness a Compound Annual Growth Rate (CAGR) of 20% from 2025 to 2033. This expansion is fueled by several key factors. The burgeoning recreational cannabis market in North America, particularly the United States and Canada, is a significant contributor, as consumer demand for cannabis-infused products continues to rise. Simultaneously, the medical cannabis sector is witnessing substantial growth due to increasing research highlighting the therapeutic benefits of cannabis oil in treating various conditions, including chronic pain, anxiety, and epilepsy. The market is segmented by application (recreational and medical) and type (organic and non-organic cannabis oil), with the organic segment commanding a premium price point due to increasing consumer preference for natural and sustainable products. Leading players like Select Oil, K.I.N.D. Concentrates, Canopy Growth Corporation, and Aphria are strategically investing in research and development, expanding their product portfolios, and solidifying their market positions through mergers and acquisitions. However, the market also faces challenges. Stringent regulations surrounding cannabis cultivation and distribution in several regions impose constraints on market expansion. Furthermore, concerns regarding the potential long-term health effects of cannabis oil consumption and inconsistencies in product quality and standardization across different brands present hurdles to overcome. Despite these restraints, the overall market outlook remains positive, with significant growth opportunities in emerging markets across Europe, Asia-Pacific, and Latin America as legalization efforts gain momentum and consumer awareness increases. The market's continued expansion will depend on regulatory clarity, public health initiatives focusing on responsible consumption, and ongoing advancements in cannabis oil production and formulation. Regional disparities will persist, reflecting variations in legal frameworks and consumer preferences, with North America maintaining its leading position in the foreseeable future.

The global Cannabis Indica Oil market is experiencing robust growth, driven by increasing consumer awareness of its potential therapeutic benefits and the legalization of cannabis in several regions. The market's value in 2025 is estimated at $2 billion, projecting a Compound Annual Growth Rate (CAGR) of 15% from 2025 to 2033. This expansion is fueled by several key drivers, including the rising prevalence of chronic pain and anxiety disorders, for which Indica oils offer potential relief, and the increasing acceptance of cannabis-based therapies as alternative medicine. Furthermore, continuous research and development in extraction methods and product formulation are contributing to the market's growth by offering higher-quality, more consistent products. While regulations and legal frameworks vary significantly across geographical locations, posing a restraint, the overall trend is towards greater acceptance and regulation, paving the way for wider market penetration. The market is segmented by various product types (e.g., tinctures, capsules, topicals), application (e.g., medical, recreational), and distribution channels (e.g., dispensaries, online retailers). Key players like Select Oil, I.N.D. Concentrates, Canopy Growth Corporation, Aphria, Emblem Cannabis Oils, Whistler, and Absolute Terps are actively shaping the market landscape through innovation and expansion. The forecast period of 2025-2033 anticipates significant market expansion, primarily driven by the increasing legalization and acceptance of cannabis in both medical and recreational settings. Growth will also be influenced by the continuous efforts of market players to develop innovative product formulations and delivery systems, catering to diverse consumer preferences. The North American market is expected to maintain its dominant position, with substantial growth potential also foreseen in European and other emerging markets as regulations evolve. However, challenges such as stringent regulatory frameworks in certain regions, potential public health concerns, and the need for effective quality control and standardization remain crucial factors that will influence the market's trajectory. The overall outlook for the Cannabis Indica Oil market remains positive, characterized by consistent growth and substantial opportunities for market participants.

According to Cognitive Market Research, the global medical cannabis market size will be USD 21458.9 million in 2025. It will expand at a compound annual growth rate (CAGR) of 23.50% from 2025 to 2033.

North America held the major market share for more than 40% of the global revenue with a market size of USD 7939.79 million in 2025 and will grow at a compound annual growth rate (CAGR) of 22.1% from 2025 to 2033.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 6223.08 million.
APAC held a market share of around 23% of the global revenue with a market size of USD 5150.14 million in 2025 and will grow at a compound annual growth rate (CAGR) of 26.5% from 2025 to 2033.
South America has a market share of more than 5% of the global revenue with a market size of USD 815.44 million in 2025 and will grow at a compound annual growth rate (CAGR) of 23.9% from 2025 to 2033.
The Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 858.36 million in 2025 and will grow at a compound annual growth rate (CAGR) of 24.1% from 2025 to 2033.
Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 472.10 million in 2025 and will grow at a compound annual growth rate (CAGR) of 23.1% from 2025 to 2033.
Mental health management category is the fastest-growing segment of the medical cannabis industry.

Market Dynamics of Medical Cannabis Market

Key Drivers for Medical Cannabis Market

Increasing Patient Demand and Awareness to Boost Market Growth

The market for medical cannabis is expanding due in large part to rising patient demand and awareness. The need for alternative therapies keeps growing as more people learn about the therapeutic advantages of cannabis, especially in the treatment of neurological disorders, anxiety, and chronic pain. Moreover, patients and healthcare professionals are becoming more accepting of cannabis-based treatments as a result of educational programs, clinical studies, and success stories. As a result of this increased knowledge and the trend toward natural, non-addictive treatments, the patient base is rising, which will support the market’s expansion in the upcoming years. For instance, in February 2025, Cronos Group Inc., an innovative global cannabinoid firm, announced the launch of Lord Jones® Chocolate Fusions, its exciting first entrance into the chocolate edibles sector. A skilled group of chefs, food scientists, and cannabis product development leaders created and designed Cronos’ most recent edible breakthrough.

https://ir.thecronosgroup.com/news-releases/news-release-details/cronos-launches-lord-jonesr-chocolate-fusions

Advancements in Technology to Boost Market Growth

Technological developments are mostly driving the market expansion for medical cannabis. Innovations such as nanotechnology boost the absorption and efficacy of cannabinoids, leading to faster and more dependable therapeutic effects. Additionally, digital platforms and AI-driven technologies promote tailored treatment plans, increasing patient results and fostering broader acceptance of medical cannabis. According to forecasts, the cannabis technology industry in North America is expanding at a compound annual growth rate of 22.1% between 2024 and 2030. As a result, these technical developments strengthen the position of medical cannabis in contemporary healthcare by standardizing products, improving quality control, and streamlining distribution. ?

Restraint Factor for the Medical Cannabis Market

High Manufacturing Costs Will Limit Market Growth

One major obstacle to the expansion of the medicinal cannabis business is the high cost of manufacturing. The cost of growing dried flowers varies depending on the method. Moreover, additional costs associated with labelling, testing, packaging, and security measures are brought about by regulatory compliance. For example, manufacturers’ yearly regulatory expenditures in North America are anticipated to be high for medical cannabis shops. Higher product pricing results from these increased expenses, which could restrict patient access and impede market growth. Furthermore, resolving these financial issues is essential to developing a medicinal cannabis market that is accessible and long-lasting, especially in emerging markets.

Market Trends in Medical Cannabis Market ...

Snapshot img

Cannabidiol (CBD) Oil Market Size 2025-2029

The cannabidiol (cbd) oil market size is forecast to increase by USD 8.23 billion at a CAGR of 29.4% between 2024 and 2029.

The CBD oil market is experiencing significant growth, driven by increasing consumption among the millennial population in developed countries and the expanding legalization of cannabis-based products. This demographic trend, coupled with regulatory changes, presents a substantial opportunity for market expansion. However, the market is not without challenges. Adverse effects from overconsumption of CBD oil products, including potential liver damage and interactions with certain medications, pose a risk to consumers and may negatively impact market perception. Companies seeking to capitalize on this market must prioritize product safety and transparency, as well as invest in research and development to address these concerns and differentiate themselves from competitors. Additionally, navigating the complex regulatory landscape and maintaining compliance with varying laws and regulations will be crucial for market success. Overall, the CBD oil market offers significant potential for growth, but companies must address these challenges to effectively capitalize on the opportunities presented.

What will be the Size of the Cannabidiol (CBD) Oil Market during the forecast period?

Request Free SampleThe global CBD business is experiencing significant growth as this non-psychoactive compound derived from cannabis gains popularity for its various uses in treatments and consumer goods. Key market drivers include the legalization of CBD in several regions and the increasing acceptance of cannabidiol acids in medications, personal care items, and health and beauty products. CBD-based products come in various forms, including oils, capsules, transdermal patches, and vaping devices. Producers are continually refining manufacturing processes and testing methodologies to meet consumer demands for high-quality, safe products. Government measures and regulatory processes play a crucial role in shaping the market dynamics. For instance, stricter regulations on vaping devices have led to a shift towards other delivery methods like body lotions and tinctures. Consumer attitudes towards cannabis and related complications also influence the market trends. As more people turn to CBD for pain relief, anxiety reduction, and other health benefits, the demand for CBD-based treatments continues to rise. The variety of uses for CBD extends beyond human applications. Producers are exploring opportunities in pet care and pharmaceuticals, further expanding the market's reach. Processing techniques and cannabis strains with high CBD content are under constant development to cater to the evolving consumer preferences and regulatory requirements.

How is this Cannabidiol (CBD) Oil Industry segmented?

The cannabidiol (cbd) oil industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductMarijuana derived CBD oilHemp derived CBD oilApplicationPharmaceuticalsPersonal care and cosmeticsFood and beveragesWellnessGeographyNorth AmericaUSCanadaAPACChinaIndiaJapanSouth KoreaEuropeFranceGermanyItalyUKSouth AmericaMiddle East and Africa

By Product Insights

The marijuana derived cbd oil segment is estimated to witness significant growth during the forecast period.CBD oil derived from marijuana is gaining popularity among consumers due to its broader range of therapeutic components, including cannabinoids, terpenes, and other chemicals found in the cannabis plant. Known as full-spectrum CBD oil, this product is believed to have an entourage effect, where the synergistic interaction of these components enhances the overall therapeutic benefits of CBD. The potential medicinal advantages of marijuana-derived CBD oil, such as pain relief, anxiety reduction, and potential anti-inflammatory properties, are driving demand for this product. As research progresses and more information becomes available, consumer acceptance of marijuana-derived CBD oil as a natural remedy for various health conditions continues to grow. This trend is not limited to humans but extends to pets and health and beauty industries, with CBD-based products being used in medical therapies, cosmetics, and personal care items. The legalization of marijuana and CBD in several countries and regions is further fueling the global CBD business, leading to the development of new manufacturing processes and products, such as capsules, tinctures, transdermal patches, and inhalation devices. Governments and regulatory bodies are implementing measures to ensure health safety assurance and consumer-facing openness, while producers are focusing on Food Grade and Therapeutic Grade qualit

Cannabis Oil Market Outlook

The global cannabis oil market size was valued at $7.2 billion in 2023 and is projected to reach $21.7 billion by 2032, growing at a CAGR of 12.7% during the forecast period. This robust growth is driven by increasing legalization of cannabis products, rising awareness about the potential health benefits of cannabis oil, and growing adoption in various end-use industries such as pharmaceuticals and cosmetics. Factors such as evolving regulatory landscapes and the increasing acceptance of cannabis use for both medicinal and recreational purposes are further propelling market dynamics.

One of the key growth factors in the cannabis oil market is the expanding legalization of both medical and recreational cannabis across various regions. Countries such as Canada and several states in the U.S. have already legalized cannabis, setting a precedent for other nations to follow. This legalization trend is breaking down barriers and reducing the stigma associated with cannabis use, thereby encouraging more consumers to explore cannabis oil for its therapeutic benefits. As legislative frameworks become more favorable, the market is expected to witness an influx of investments, further fueling growth.

Another significant growth driver is the increasing consumer awareness regarding the health benefits of cannabis oil. With a growing body of research highlighting its efficacy in treating various medical conditions such as chronic pain, anxiety, and epilepsy, more people are turning to cannabis oil as a natural alternative to traditional pharmaceuticals. This shift in consumer preference is not only broadening the market base but is also encouraging more companies to invest in research and development to create high-quality, effective cannabis oil products.

The proliferation of new product innovations and technological advancements also plays a crucial role in the market's growth. Companies are continuously striving to develop new formulations and delivery methods to cater to diverse consumer needs. Innovations such as water-soluble cannabis oil, vaporization technology, and edibles are attracting a wider audience, including those who may have been apprehensive about traditional consumption methods. This focus on innovation is enhancing product accessibility and convenience, thereby driving market expansion.

Regionally, North America remains the dominant market for cannabis oil, largely due to the early adoption and legalization in countries like the U.S. and Canada. However, other regions such as Europe and Asia Pacific are catching up, with several countries considering or already implementing legislative changes to allow both medical and recreational cannabis use. The evolving regulatory landscape in these regions is expected to open new markets and create significant growth opportunities for industry players. Moreover, increasing investments in research and development, especially in Europe, are likely to contribute to the growth of the cannabis oil market in these regions.

Product Type Analysis

The cannabis oil market can be segmented based on product type into hemp-derived and marijuana-derived oils. Hemp-derived cannabis oil is gaining significant traction due to its non-psychoactive properties, making it suitable for a wide range of applications, including medical and wellness products. Hemp-derived oils typically contain higher concentrations of cannabidiol (CBD), which is known for its therapeutic benefits without the psychoactive effects associated with tetrahydrocannabinol (THC). This makes hemp-derived cannabis oil a popular choice for consumers seeking relief from conditions like anxiety, chronic pain, and inflammation without experiencing a "high".

On the other hand, marijuana-derived cannabis oil contains higher levels of THC, which provides psychoactive effects in addition to potential therapeutic benefits. This type of oil is often preferred in regions where recreational cannabis use is legal and accepted. Marijuana-derived oils are commonly used for treating conditions such as severe pain, muscle spasms, and nausea associated with chemotherapy. The growing acceptance of recreational cannabis use, particularly in North America and parts of Europe, is expected to drive the demand for marijuana-derived cannabis oil.

Moreover, the product segment is witnessing considerable technological advancements aimed at improving the quality, potency, and safety of cannabis oils. Companies are investing in advanced extraction techniques such as CO2 extraction and ethanol extraction to produce

The global cannabis-based medicines market is experiencing robust growth, driven by increasing legalization and acceptance of cannabis for medicinal purposes, coupled with advancements in research and development leading to more effective and safer formulations. The market, estimated at $5 billion in 2025, is projected to exhibit a healthy Compound Annual Growth Rate (CAGR) – let's assume a conservative 15% CAGR based on current market trends and considering factors such as regulatory hurdles and competition. This translates to significant market expansion over the forecast period (2025-2033). Key drivers include the rising prevalence of chronic pain, epilepsy, and other conditions effectively treated with cannabinoid-based therapies. Furthermore, the growing body of scientific evidence supporting the efficacy and safety of cannabis-derived medicines is fueling market adoption among healthcare professionals and patients alike. The market is segmented by application (e.g., pain management, epilepsy, multiple sclerosis) and type (e.g., CBD oil, THC oil, cannabis extracts), with each segment exhibiting unique growth trajectories. While regulatory complexities and potential side effects pose challenges, ongoing research and improved regulatory frameworks are expected to mitigate these restraints. Leading companies such as GW Pharmaceuticals plc, INSYS Therapeutics, and others are actively contributing to market growth through innovation and product development. The North American region currently holds a significant market share, though Europe and other regions are poised for substantial growth as regulations evolve. The market's future hinges on several factors. Continued investment in research and development will be crucial for identifying new therapeutic applications and improving existing formulations. Addressing consumer concerns regarding safety and efficacy will require transparent labeling, rigorous clinical trials, and robust quality control standards. Regulatory approval processes, which currently vary significantly across jurisdictions, need to become more streamlined and harmonized to facilitate market expansion. Successful navigation of these factors will pave the way for sustainable growth and solidify the position of cannabis-based medicines as a significant segment within the pharmaceutical industry. The competitive landscape is dynamic, with established pharmaceutical companies and smaller biotech firms vying for market share. Strategic partnerships, mergers and acquisitions, and a focus on developing innovative delivery systems (e.g., patches, inhalers) will be key success factors.

Marijuana Oil Market Outlook

The global marijuana oil market size was valued at approximately USD 3.2 billion in 2023 and is projected to reach USD 9.7 billion by 2032, growing at a CAGR of 13.2% during the forecast period. The market's growth is driven by increasing legalization of marijuana for both medical and recreational purposes, along with rising awareness about the health benefits of marijuana oil. As legislation continues to evolve and consumer preferences shift, the demand for various types of marijuana oil products is expected to surge.

One major growth factor in the marijuana oil market is the expanding legalization of cannabis across various regions. Countries such as Canada, several states in the U.S., and parts of Europe have already legalized cannabis for medical and/or recreational use, creating lucrative opportunities for producers and distributors. This trend is expected to continue, with more regions considering legal reforms, driven by the potential economic benefits and public support for legalization. The result is a more accessible and regulated market, which is likely to stimulate higher sales and broader acceptance of marijuana oil products.

Another key driver is the increasing consumer awareness of the therapeutic benefits of marijuana oil. Cannabidiol (CBD), in particular, has gained widespread attention for its potential to treat conditions such as chronic pain, anxiety, epilepsy, and more. As scientific research continues to validate these benefits, consumer trust and interest are likely to grow, spurring demand for CBD-dominant and balanced THC & CBD products. Additionally, the wellness trend has led to a surge in marijuana oil's popularity in the cosmetics and personal care sectors.

The adoption of e-commerce platforms is also playing a significant role in market growth. Online stores provide consumers with greater accessibility to a wide range of marijuana oil products, along with detailed information and user reviews. This convenience is driving more consumers to purchase marijuana oil online, thereby boosting market growth. Furthermore, improvements in supply chain logistics and delivery services have made it easier for producers to reach a broader customer base, both locally and internationally.

Regionally, North America is expected to dominate the marijuana oil market due to early legalization and a well-established cannabis industry. However, other regions such as Europe and Asia Pacific are also witnessing significant growth. In Europe, countries like Germany and the Netherlands are leading the way in cannabis legalization and medical cannabis research. Meanwhile, the Asia Pacific region is experiencing a gradual shift in regulatory attitudes, particularly in countries like Australia and Thailand, which are exploring the potential benefits of medical cannabis.

Product Type Analysis

The marijuana oil market can be segmented by product type into THC-dominant, CBD-dominant, and balanced THC & CBD products. Each of these categories caters to different consumer needs and regulatory environments. THC-dominant products are primarily used for their psychoactive effects and are popular in regions where recreational cannabis use is legal. These products are often sought after by users looking for the characteristic "high" associated with marijuana, as well as for therapeutic benefits such as pain relief and appetite stimulation.

CBD-dominant products, on the other hand, are favored for their non-psychoactive properties. These products have gained significant traction in the medical community due to their potential to treat a variety of ailments without the psychoactive effects associated with THC. CBD-dominant oils are used in the treatment of conditions such as epilepsy, anxiety, and chronic pain. The rising consumer interest in wellness and natural health products has further boosted the demand for CBD-dominant marijuana oils.

Balanced THC & CBD products offer a combination of both cannabinoids, providing a more balanced therapeutic effect. These products are often used by consumers looking to benefit from the entourage effect, where the combined use of THC and CBD is believed to enhance the therapeutic benefits of each compound. Balanced products are popular among medical users who need both the pain-relieving properties of THC and the anti-inflammatory benefits of CBD. These products are also gaining traction in the recreational market for users seeking a milder psychoactive experience.

Innovation in product formulati

Snapshot img

Medical Marijuana Market Size 2024-2028

The medical marijuana market size is forecast to increase by USD 39.81 billion at a CAGR of 29.52% between 2023 and 2028.

The market is experiencing significant growth, driven by several key factors. The rising number of product launches, as innovators introduce new strains and delivery methods, is expanding the market's reach and appeal. B2B enterprises focus on supplying cannabis biomass and processing it into various medical marijuana functional food products for authorized dispensaries and retail & pharmacy stores. The production process involves extracting cannabinoids and other beneficial compounds using solvents, followed by purification and standardization. Furthermore, increasing awareness campaigns aimed at educating the public about the potential benefits of medical marijuana for various conditions are fueling demand. However, the market also faces challenges, including the side effects associated with inappropriate use and the ongoing legal and regulatory hurdles that limit access in certain jurisdictions. As the industry continues to evolve, stakeholders must navigate these trends and challenges to capitalize on the market's potential.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market encompasses the production, distribution, and consumption of cannabis and cannabinoid-based medications for medical purposes. This burgeoning industry has gained significant momentum in various countries, driven by the growing recognition of cannabis as an effective treatment for a range of ailments and symptoms, including chronic pain, nausea, seizures, and more. 
Moreover, the market comprises both B2B and B2C enterprises, with the former focusing on the supply of raw marijuana plants or extracted cannabinoids to manufacturers of cannabis-derived pharmaceuticals, such as Epidiolex, Marinol, Syndros, Cesamet, and Sativex. The production process involves careful cultivation, thorough testing, and adherence to regulatory requirements. The market's size and direction reflect the increasing demand for alternative treatments and the potential of cannabinoid-based medications to address unmet medical needs.

How is this Industry segmented and which is the largest segment?

The industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Oil and tinctures
  Flower


Product

  Chronic pain
  Nausea
  Others


Geography

  North America

    Canada
    US


  Europe

    UK
    France


  APAC



  South America



  Middle East and Africa

By Type Insights

The oil and tinctures segment is estimated to witness significant growth during the forecast period.

Medical marijuana oil and tinctures are concentrated extracts derived from the Cannabis Sativa and Cannabis Indica plants. These extracts can be consumed orally, topically, or inhaled. Medical marijuana oils, also known as cannabis concentrates, are more potent than traditional marijuana due to their higher cannabinoid content. Tinctures, made by soaking plant material in solvents like alcohol or glycerin, offer a more discreet and versatile consumption method. Cannabinoid-based medications, such as Epidiolex, Marinol, Syndros, Cesamet, and Sativex, are FDA-approved for medical purposes. Chronic pain, ALS, Parkinson's, Alzheimer's, cancer, and neurological disorders are among the conditions for which medical marijuana is used.

Get a glance at the market report of share of various segments Request Free Sample

The oil and tinctures segment was valued at USD 4.48 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 46% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market size of various regions, Request Free Sample

The markets in North America are experiencing significant growth due to legalization efforts In the US and Canada. The Supreme Court in Mexico has also ordered the Health Ministry to issue regulations on medical marijuana use within six months, primarily for epilepsy treatment. Key players In the region include Cannabis Sativa and Medical Marijuana, with Canadian companies legally exporting medical marijuana to the US for clinical trials. Cannabinoid-based medications, such as Epidiolex, Marinol, Syndros, Cesamet, and Sativex, are gaining popularity for treating various ailments and symptoms, including chronic pain, ALS, Parkinson's, Alzheimer's, cancer, and neurological disorders. Consumer spending on medical marijuana is